New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 27, 2012
07:07 EDTCBLICleveland BioLabs subsidiary signs contract for about $4.6M with Russia
Cleveland BioLabs and Panacela Labs announced award of a contract valued at 146 million rubles, or approximately $4.6M with the Ministry of Industry and Trade of the Russian Federation for development of Xenomycins, a family of compounds in development as anti-infective agents. The contract, issued under the Russian Federation's "Pharma 2020" development initiative, provides matching funding over a period of approximately three years, which will be used to support preclinical and clinical studies.
News For CBLI From The Last 14 Days
Check below for free stories on CBLI the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 15, 2014
07:10 EDTCBLICleveland BioLabs announces approval to start CBLB612 Phase 1 study in Russia
Subscribe for More Information
September 10, 2014
07:37 EDTCBLICleveland BioLabs announces extra 180 days to regain NASDAQ compliance
Subscribe for More Information
September 8, 2014
07:06 EDTCBLICleveland BioLabs, Sabby announce resolution of litigation
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use